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Summary
Resveratrol, a natural phytoalexin found in grapes and
red wine [1], increases longevity in the short-lived in-
vertebrates Caenorhabditis elegans and Drosophila
[2–5] and exerts a variety of biological effects in verte-
brates, including protection from ischemia and neuro-
toxicity [6–10]. Its effects on vertebrate lifespan were
not yet known. The relatively long lifespan of mice,
which live at least 2.5 years [11], is a hurdle for life-
long pharmacological trials. Here, the authors used
the short-lived seasonal fish Nothobranchius furzeri
with a maximum recorded lifespan of 13 weeks in cap-
tivity [12, 13]. Short lifespan in this species is not the re-
sult of spontaneous or targeted genetic mutations [14],
but a natural trait correlated with the necessity to breed
in an ephemeral habitat and tied with accelerated de-
velopment and expression of ageing biomarkers at
a cellular level [12, 13]. Resveratrol was added to the
food starting in early adulthood and caused a dose-de-
pendent increase of median and maximum lifespan. In
addition, resveratrol delays the age-dependent decay
of locomotor activity and cognitive performances and
reduces the expression of neurofibrillary degeneration
in the brain. These results demonstrate that food sup-
plementation with resveratrol prolongs lifespan and
retards the expression of age-dependent traits in a
short-lived vertebrate.
Results
Effects of Resveratrol on Longevity
We hatched and raised fishes (n = 157) under standard
conditions (for details refer to [13]) until 4 weeks, when
*Correspondence: cellerino@in.cnr.itthey reach sexual maturity [12]. Throughout the re-
maining part of their life, 110 fishes were fed food sup-
plemented with resveratrol at three different concentra-
tions: 24 mg/g food (0.1 mM; n = 30), 120 mg/g food
(0.5 mM; n = 60), and 600 mg/g food (2.5 mM; n = 20), while
47 control fishes continued to receive standard food.
Fishes were not fed ad libitum, but received a defined
dose of food twice a day (see Experimental Procedures).
Therefore, it can be excluded that resveratrol effects are
confounded by food aversion behaviors that result in di-
etary restriction. Survival of control-fed fishes is almost
identical to the survival of a larger number of untreated
individuals that represent our reference data (n = 132,
Figure 1A). Supplementation of resveratrol resulted in
a statistically significant increase of longevity that was
dose dependent: the lowest dose (24 mg/g food) was in-
effective in increasing lifespan compared to both con-
trol-fed and untreated fishes (Figure 1A). In two indepen-
dent trials, 120 mg/g food caused an increase of median
and maximum lifespan of 33% and 27%, respectively
(p < 0.001, log rank test; Figure 1A), and 600 mg/g food
induced 56% and 59% increase in median and maxi-
mum lifespan, respectively (p < 0.001, log rank test; Fig-
ure 1A). 600 mg/g food was significantly more effective
than 120 mg/g food in prolonging lifespan (p = 0.01, log
rank test) (maximum lifespan in demographic studies
is defined as the 10th percentile in survival). Life exten-
sion was observed both in males and females (Figure 1B)
and did not differ between the two sexes. Longevity was
not linked to loss of fertility: resveratrol-treated females
continued to lay eggs and males were still fertile (i.e.,
were able to fertilize eggs) at age 12 weeks when all con-
trols had died. Eggs laid by resveratrol-treated fishes
developed into normal adults (not shown).
Demographic data can be analyzed by an exponential
fit of age-dependent mortality rates that separate two
components: an age-independent mortality (mortality
unrelated to aging) and an exponential increase of mor-
tality rates (which is thought to reflect time-dependent
accumulation of irreversible biochemical damage [15]).
Resveratrol changed the slope of the mortality curve,
slowing down the age-dependent increase in death
rate, and interestingly increases the intercept, i.e., raises
the mortality rates of treated fishes over those of con-
trol-fed fishes during the first weeks after administration
(Figure 1C). This datum suggests an early hormetic role
of resveratrol as a possible mechanism of action for the
induction of slowed aging and prolonged lifespan.
Effects of Resveratrol on Functional Markers
Age-related reduction of locomotor efficiency is a marker
for neuromuscular decay [16]. Wequantified spontaneous
locomotor activity by scoring of videotapes starting from
week 5. Statistical analysis revealed reduction in sponta-
neous swimming at 9 weeks in control animals (Figure 2A,
Kruskall-Wallis rank-based ANOVA, p < 0.001); this reduc-
tion is retarded in resveratrol-treated fishes (120 mg/g
food, differences between treated and control group at 9
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297Figure 1. Age-Dependent Survival of Treated and Untreated Nothobranchius furzeri
The fraction of animals survived is plotted on the ordinate, and the age (in weeks) is plotted on the abscissa. The origin of the curves is at age 4
weeks, when the fishes are sexually mature and the treatment starts.
(A) Survival curves of five separate experiments and of a reference set for a total of 289 animals. Two trials of control-fed fishes (solid and empty
red triangles, total number = 47); reference survival of untreated fishes (black dotted, n = 132, a total of 5 replicates); 24 mg/g resveratrol-treated
fishes (green, n = 30); two trials of 120 mg resveratrol-treated fishes (solid and empty black circles, total number = 60; 4 fishes were sacrificed for
histological analysis and censored at age 9 weeks); 600 mg resveratrol-treated fishes (blue, n = 20).
(B) Comparison between the age-dependent survival of males and females in controls and 120 mg/g resveratrol-treated fishes. Control males
(black line, n = 22) and females (dotted black line, n = 25); 120 mg/g resveratrol-treated males (blue line, n = 30) and females (dash and dot
line, n = 27). Three animals could not be sexed upon death.
(C) Death trajectories in controls (black, y = 1.0452x – 4.4726; R2 = 0.9402) and 120 mg/g resveratrol-treated fishes (red, y = 0.3761x – 2.3177;
R2 = 0.9739). The linear interpolations are performed for both groups from week 6 to the 10% survivorship age (week 11 for controls, week
14 for treated fishes).weeks significant by two-way ANOVA, Tukey post hoc
test: p < 0.001). Open-field exploration, a standard behav-
ioral test in the rodent that quantifies the exploration of
a new environment [17], was quantified by automated
video tracking. Age-dependent decrease in time spent
moving and average velocity was detected at 9 weeks in
control fishes when compared to 5-week-old fishes (Fig-
ures 2B and 2C, Kruskall-Wallis rank-based ANOVA, p <
0.01). Locomotor function was preserved in 9-week-old
treated fishes (two-way ANOVA, Tukey’s post hoc test:
p < 0.001). The swimming performance increased, instead
of decreasing, in resveratrol-treated fishes until the 10th
week and decayed in 13-week-old fishes (Kruskall-Wallis
rank-based ANOVA, p < 0.001).
We quantified operant learning in Nothobranchius
furzeri by a modified shuttle-box originally developedfor goldfish and zebrafish [18, 19] (see Figure S1 in the
Supplemental Data available with this article online), in
order to evaluate an age-dependent cognitive decline.
Young fishes (n = 10; 5 weeks old) learned the task effec-
tively and after 50 consecutive trials attained 73% rate of
successes (Figure 2D). Old fishes (n = 10; 9 weeks old)
showed significant learning, but at the end of the train-
ing their success rate only reached 42% (Figure 2D).
Age-dependent decay of cognitive performances was
completely prevented in old fishes treated with resvera-
trol (120 mg/g food), which reached 74% rate of suc-
cesses (n = 10; 9 weeks old, Kruskall-Wallis rank-based
ANOVA, p < 0.001; Figure 2D; Figure S1).
Neurofibrillary degeneration was used as a histologi-
cal marker of neuronal aging [20]. Young fishes (n = 4;
5 weeks old) did not show signs of neurofibrillaryFigure 2. Functional Aging in Treated and
Untreated Nothobranchius furzeri
(A–C) Locomotor activity.
(A) Fraction of fishes swimming in a 5 s time
frame is reported on the ordinate.
(B) Average swimming velocity during open-
field exploration.
(C) Time spent moving during open-field
exploration. The age (in weeks) is reported
on the abscissa. Open circles refer to controls
and solid circles refer to 120 mg/g resvertarol-
treated fishes. Error bars are standard errors.
Pair-wise comparisons were performed by
Kruskall-Wallis rank-based ANOVA, **p < 0.01,
***p < 0.001.
(D) Cognitive test. Scatter of individual top
scores in an active avoidance test (Figure S1).
Solid circles refer to individual animals of the
three groups and the barred circles to the av-
erages of the three groups. Treated fishes are
120 mg/g food resveratrol-fed fishes. Pair-
wise comparisons were performed with Krus-
kall-Wallis rank-based ANOVA, ***p < 0.001.
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298Figure 3. Neurofibrillary Degeneration in a
Horizontal Section of Stratum Griseum
Superficiale of the Optic Tectum
Lateral is right and medial is left. Fluoro-
JadeB histochemistry. The specific reaction
product is fluorescent green.
(A) 5-week-old fish. Note absence of specific
signal.
(B) 9-week-old control fish. Note the bright la-
beling in neuronal processes orthogonal to
the tectal surface.
(C) 9-week-old 120 mg/g resveratrol-treated
fish.
(D) Quantification of labeling intensity. Gray
level values are normalized with respect to
the average gray value of controls, which is
arbitrarily set to 100. Bars represent standard
errors of means.degeneration (Figure 3A), but old fishes (n = 4; 9 weeks
old) showed neurofibrillary labeling of dendrites in the
optic tectum (Figure 3B) as well as telencephalon and
brainstem (not shown), as detected by Fluoro-JadeB
staining. Labeling was absent in resveratrol-treated old
fishes (n = 4, Figure 3C). This difference was quantified
by image analysis (Figure 3D).
Discussion
In the present paper we tested the effects of resveratrol
on the lifespan and on the onset of age-related markers
in the short-lived fishNothobranchius furzeri, a seasonal
fish whose recorded median lifespan in captivity is 9
weeks [13]. This short captive lifespan is a natural trait
observed also in one wild-derived population collected
by the authors in 2004 (D.R.V., E.T., and A. Cellerino, un-
published data). Other longer-living natural populations
of Nothobranchius furzeri exist, and they originate from
a more humid habitat (unpublished data), in line with the
relationship between length of the rain season and cap-
tive lifespan observed in Nothobranchius species [13].
The biological action of resveratrol, we report here, ex-
tend to vertebrates the longevity effect of resveratrol
originally described in yeast, Drosophila, and C. elegans
[3, 5]. The effects of resveratrol were not coupled to loss
of fertility, in agreement with the effects found by others
in C. elegans and Drosophila [5]. More importantly, this
effect was observed with treatments starting in early
adult life and effected functional parameters such as lo-
comotor activity and cognitive deficit, which are ob-
served during vertebrate and human aging [21–24]. A
complex dietary supplement was shown to cause a small
extension of longevity in mice [25], and supplementation
of L-Acetyl-Carnitine was shown to retard rat locomotor
and cognitive aging [22, 23].The natural polyphenol resveratrol has received much
attention for its possible pharmacological use. It was re-
ported to have anticancer and antiinflammatory action in
vitro [26, 27] and neuroprotective action in vitro [6, 7, 9,
10, 28] and in vivo [10]. The mechanisms of action of
resveratrol are multiple [1]. It inhibits mitochondrial
ATPase in mammals [29, 30] and was reported to acti-
vate the NAD-dependent hystone deacetylase sirtuins
in nematodes, flies, and rodents [5, 6]. The effects of re-
sveratrol in nematodes and flies require the presence of
a functional Sir2 gene [5]. Overexpression of the mam-
malian homolog of sir2, SIRT1, has reported to be neuro-
protective in a variety of models, and this effect is mim-
icked by resveratrol [6, 7, 28]. Finally, dietary restriction,
the best-studied life-extension treatment, causes over-
expression of SIRT1 [31], and its effects on lifespan
are not additive to those of resveratrol in Drosophila
[5]. All these data raise the possibility that resveratrol
mimics dietary restriction by decreasing the aging rate
though activation of SIRT1. However, more recent re-
sults have shown that resveratrol increases Sir2 or
SIRT1 activity only if the substrate is conjugated to a
nonphysiological fluorescent moiety [32, 33]. So, at
present, the mechanism underlying the life-extension
property of resveratrol and its relationship with calorie
restriction remain unclear. The effect of resveratrol is
mimicked by overexpression of sirtuins [6, 7, 28], but
does not seem to be mediated by direct action on sir-
tuins [32, 33].
Life extension by resveratrol is associated with
a change in the slope of the mortality trajectory, i.e.,
the time-dependent increase in death risk is lowered in
resveratrol-fed fishes compared to control-fed ones. A
similar effect is observed in Drosophila when the tem-
perature is reduced and was linked to a reduction in
the age-dependent accumulation of biochemical irre-
versible damage [34]. This effect is different from the
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least in Drosophila, is tied to time-restricted reduction
in the acute risk of death without changes in the slope
of the mortality rate [34]. If this interpretation can be ex-
tended to N. furzeri, it would further suggest caution
when equating the effects of resveratrol with dietary re-
striction. We observed that resveratrol induced an early
increase in death rate after administration, suggesting a
possible hormetic role, i.e., its weakly toxic action would
stimulate a stress response and eventually increase life-
span and retard ageing. This view is in agreement with
the resveratrol-dependent activation of detoxification
enzymes observed in in vitro studies [35].
Resveratrol has shown neuroprotective activity in a
variety of paradigms both in vivo and in vitro [6, 7, 9,
10, 28]. Invertebrate studies have revealed the impor-
tance of the nervous system in regulating lifespan, as
neuronal-specific gene manipulations and neuroprotec-
tive drugs can change the longevity of both worms and
flies [2, 36–38]. Resveratrol-fed fishes showed remark-
able preservation of operant learning and prevention of
age-dependent neurodegeneration. The possibility can-
not be excluded that life extension induced by resvera-
trol is secondary to a protective action on the nervous
system.
The mechanisms by which resveratrol prolongs life-
span in model organism are not clear, but the observation
that its supplementation with food extends vertebrate
lifespan and delays motor and cognitive age-related
decline could be of high relevance for the prevention of
aging-related diseases in the human population.
Experimental Procedures
Fish Maintenance
Fishes used for this study are of the Gonarezhou strain of Notho-
branchius furzeri kept at 25ºC since the 4th week of life. We main-
tained a tank density of 20 fishes, which were fed twice a day with
commercially available bloodworm larvae (Chironomus sp.). The wa-
ter was changed once a week and was filtered by a sponge filter
driven by air supply that provided a soft filtration. For details on rais-
ing Nothobranchius sp., refer to [13].
Resveratrol Treatment
Sample preparation for 120 mg/food: 1.2 mg/ml resveratrol stock
was prepared in 5% ethanol and stored at 4ºC in the dark. Frozen
Chironomus larvae were thawed, left to drip dry, and aliquoted
into portions of one feeding for 10 adult fish (1 g). 100 ml of the
1.2 mg/ml stock was added to each Chironomus aliquot, which
was left at 4ºC for 1–2 hr to soak. 5% gelatine was added to the Chi-
ronomus/resveratrol aliquot, mixed, frozen, and stored at220ºC un-
til use. For feeding, the frozen gelatine/Chironomus cube was
thawed in water and fed to the fish. All uneaten food was removed.
Fish received 2 feeding per day. Control-fed fishes received the
same kind of food lacking resveratrol in the stock solution. The
food consumption was approximately of 50 mg (food)/g (fish
weight)/day.
Survival Assays
Fishes were counted once a week, and each day dead fishes were
scored and removed from the tanks. The commercial available
Graph Pad Prism was used for survival analysis. Death trajectories
were computed as the ln(2ln(fraction survived)).
Locomotion Tests
Animals for the behavioral tests are a subset of the animals used for
the survival curve. For analysis of spontaneous locomotion, fishes
were filmed for 1 hr in their home tank at a frame rate of 1 frame
per s. Ten couples of frames from the movie strain were extractedin the following way: each frame couple consisted of two frames oc-
curring 5 s apart. A fish was considered to be significantly displaced
from one frame to the other if it moved for at least one half of its body
length. The fraction of fishes actively swimming in each frame was
scored manually and averaged. For open-field exploration, 5 males
and 5 females were selected randomly from the survivors. Each fish
was moved to a new tank and filmed. Clips were analyzed by stan-
dard procedures of Ethovision (Noldus, Waningen, The Nether-
lands).
Active Avoidance
Learning in fish can be studied with a protocol of operative condi-
tioning with a modification of the shuttlebox [18]. The fish is placed
in a tank with a divider and one red light in each compartment (see
Figure S1). The fish is left to habituate to the new environment for
about 1 hr before starting the test. When the fish is in one compart-
ment, the light is switched on for 30 s, and after a delay of 15 s the
fish receives a punishment if it remains within the same compart-
ment. Each of these events is a trial. If the fish moves to the other
compartment within 15 s from light onset, the fish avoids the punish-
ment and the trial is scored as successful (Figure 2D). Frequency of
success is averaged over ten consecutive trials and the top scores
are used as Performance Index for statistical analysis. Details of
the apparatus and quantifications are in Figure S1.
Histology
Fish were euthanized with MS-222 and placed on crushed ice for
dissection. Tissues were immersion fixed, cryoprotected, included,
and sliced by standard techniques. Horizontal sections from the op-
tic tectum of 9-week-old controls (n = 4) and 9-week-old 120 mg/g
resveratrol-treated fishes (n = 4) were reacted for Fluoro-JadeB
histochemistry in the same session and acquired at the confocal
microscope at fixed laser intensity, photomultiplier parameters,
and pinhole size during the same day. Fluorescence analysis was
performed with Metamorph. For each subject, three rectangular
frames of fixed size were acquired close to the pial surface and
the images were thresholded at a fixed intensity value so that all
pixels below threshold were excluded from the analysis. The aver-
age fluorescence intensity within the thresholded area was then cal-
culated.
Supplemental Data
Supplemental Data include one figure and can be found with this ar-
ticle online at http://www.current-biology.com/cgi/content/full/16/
3/296/DC1/.
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